top
Search terms
Results 1 - 10 of 13 - ordered by :
Pages: 1 2
Ejhf

The use of disease-specific composite mortality–morbidity endpoints instead of all-cause mortality was largely pioneered in these trials.2–7 Similarly, in order to achieve sufficient power in an ...

European Journal of Heart Failure, McMurray, John J.V., Swedberg, Karl

Date : 01/02/2010 Item size : 106488 bytes
Ehjcvp

Thanks to these investigations, European and American scientific societies have developed guidelines that provide evidence-based recommendations for treating acute and chronic HF,1,2 including ...

European Heart Journal - Cardiovascular Pharmacotherapy, EDITORIAL, Francesco Pelliccia, Giuseppe M.C. Rosano

Date : 01/01/2015 Item size : 131344 bytes
Ehjcardiovascrec

Whether this also holds for patients with chronic heart failure is at present unsettled, but obviously, these patients would benefit most from sinus rhythm since with restoration and maintenance of ...

Cardiovascular Research, Editorial, Isabelle C. Van Gelder

Date : 01/04/2007 Item size : 171177 bytes
Heart

Trastuzumab-induced cardiotoxicity in early breast cancer patients: a retrospective study of possible risk and protective factors Objective Although adjuvant trastuzumab improves survival in ...

Heart, Heart failure, Alberto Farolfi, Elisabetta Melegari, Michele Aquilina, Emanuela Scarpi, Toni Ibrahim, Roberta Maltoni, Samanta Sarti, Lorenzo Cecconetto, Elisabetta Pietri, Cristiano Ferrario, ...

Date : 01/05/2013
Ehjournal

The use of ACE inhibitors and also of ARBs was later expanded to patients with an increased global cardiovascular (CV) risk, patients with stable coronary artery disease (CAD), diabetic patients ...

European Heart Journal, Ruilope, Luis M.

Date : 07/07/2014 Item size : 151111 bytes
Ehjournal

Published Guidelines uniformly provide reninangiotensin system (RAS) inhibitors with a class IA recommendation for the treatment of patients with symptomatic heart failure (HF) due to systolic ...

European Heart Journal, Dickstein, Kenneth

Date : 07/09/2015
Ehjcardiovascrec

Whether this also holds for patients with chronic heart failure is at present unsettled, but obviously, these patients would benefit most from sinus rhythm since with restoration and maintenance of ...

Cardiovascular Research, Van Gelder, Isabelle C.

Date : 01/04/2007 Item size : 147212 bytes
Ehjournal

The use of ACE inhibitors and also of ARBs was later expanded to patients with an increased global cardiovascular (CV) risk, patients with stable coronary artery disease (CAD), diabetic patients ...

European Heart Journal, Ruilope, Luis M.

Date : 07/07/2014 Item size : 171965 bytes
Ehjcardiovascrec

Whether this also holds for patients with chronic heart failure is at present unsettled, but obviously, these patients would benefit most from sinus rhythm since with restoration and maintenance of ...

Cardiovascular Research, Van Gelder, Isabelle C.

Date : 01/04/2007 Item size : 139821 bytes
Ejhf

The use of disease-specific composite mortality–morbidity endpoints instead of all-cause mortality was largely pioneered in these trials.2–7 Similarly, in order to achieve sufficient power in an ...

European Journal of Heart Failure, McMurray, John J.V., Swedberg, Karl

Date : 01/02/2010 Item size : 107248 bytes